Physician profile
Timothy Huckaby
NPI 1659333284
$802.66
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.49 · 2020: $181 · 2021: $17.48 · 2023: $496 · 2024: $48.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $216.06 | 2023-2024 | |
| Indivior INC. | $203.86 | 2019-2023 | Sublocade |
| Alkermes, INC. | $166.60 | 2019-2024 | Vivitrol, Vivitrol |
| Uswm, LLC | $61.72 | 2023 | Lucemyra |
| Neurocrine Biosciences, INC. | $53.52 | 2023 | Ingrezza |
| Braeburn INC. | $30.12 | 2023 | Brixadi |
| Axsome Therapeutics, INC. | $23.68 | 2023 | Auvelity |
| Masimo Corporation | $18.68 | 2023 | Bridge |
| Gilead Sciences, INC. | $14.57 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $13.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Huckaby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.